DIABETES NATIONAL RESEARCH GROUP

EIN: 330950812 501(c)(3)

PORT SAINT LUCIE, FL

Total Revenue
$6,306
Total Expenses
$33,820
Total Assets
N/A
Net Assets
N/A
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2000
Legal Domicile
FL
Principal Officer
PAMELA HOUGHTEN
Phone
7723454800
Tax Period
2020-07-01 to 2021-03-31

DIABETES NATIONAL RESEARCH GROUP, founded in 2000, is a micro nonprofit that reported $6K in total revenue in fiscal year 2020. Revenue fell 69% from the prior year — a significant decline worth monitoring. Expenses of $34K exceeded revenue, resulting in a 436% operating deficit.

Mission

DIABETES NATIONAL RESEARCH GROUP (DNRG)SUPPORTS FUNDAMENTAL RESEARCH TO FIND TREATMENTS AND POSSIBLE CURES, INCLUDING VACCINES, FOR TYPE 1 AND TYPE 2 DIABETES. A DEADLY DISEASE, DIABETES OCCURS WHEN THE PANCREAS DOES NOT PRODUCE OR PROPERLY USE THE HORMONE CALLED INSULIN. THIS HORMONE IS NEEDED FOR EVERY DAY LIFE. THE NEED FOR CONTINUED RESEARCH TOWARDS TREATMENTS AND CURES IS STRONG, AND DNRG IS COMMITTED TO SUPPORT RESEARCH, COLLABORATIONS, AND EDUCATION OF THE PUBLIC, IN ORDER TO MAKE A DIFFERENCE.

Program Service Accomplishments

Program 1
Expenses: $32,691 Revenue: $0

IN TYPE 1 DIABETES, CELLS IN THE PANCREAS THAT PRODUCE INSULIN ARE "ATTACKED" BY THE BODY'S OWN T-CELLS. T-CELLS ARE THE BODY'S IMMUNE CELLS WHOSE JOB IT IS TO DESTROY INVADING ORGANISMS. BUT IN TYPE...

Read more

IN TYPE 1 DIABETES, CELLS IN THE PANCREAS THAT PRODUCE INSULIN ARE "ATTACKED" BY THE BODY'S OWN T-CELLS. T-CELLS ARE THE BODY'S IMMUNE CELLS WHOSE JOB IT IS TO DESTROY INVADING ORGANISMS. BUT IN TYPE 1 DIABETES, THESE T-CELLS ALSO ATTACK THE BODY THAT THEY ARE SUPPOSED TO PROTECT. FUNDED BY THE NATIONAL INSTITUTES OF HEALTH AND THE DIABETES NATIONAL RESEARCH GROUP, SCIENTISTS IN SAN DIEGO ARE BEGINNING TO UNDERSTAND HOW THE PANCREATIC SELF-ANTIGENS (SUBSTANCES CAPABLE OF INDUCING AN IMMUNE RESPONSE)ARE PROCESSED AND PRESENTED. MANY GRANTING AGENCIES DO NOT PROVIDE SUFFICIENT FUNDS TO COVER UNEXPECTED EXPENSES, TO PURCHASE VITAL LABORATORY EQUIPMENT, OR TO SUPPORT SCIENTISTS' TRAVEL TO MEET WITH OTHERS IN THE FIELD. BY PROVIDING SUPPLEMENTAL GRANT FUNDS, THE DIABETES NATIONAL RESEARCH GROUP IS IN EFFECT WORKING IN PARTNERSHIP WITH OTHER GRANTING ORGANIZATIONS TO ENSURE THAT THIS IMPORTANT WORK CONTINUES. DURING THE PAST YEAR, DIABETES NATIONAL RESEARCH GROUP PROVIDED SUPPORT FOR THESE TYPES OF SUPPLEMENTAL OR "COST SHARING" PROGRAMS. DNRG AWARDED GRANTS FOR RESEARCH PROJECTS RELATED TO TYPE 1 AND TYPE 2 DIABETES. FUNDS WERE USED FOR NEW LABORATORY EQUIPMENT, LABORATORY SUPPLIES, SCIENTISTS' SALARIES, AND TRAVEL TO SCIENTIFIC MEETINGS. TRAVEL TO MEETINGS IS CRUCIAL IN ORDER TO ESTABLISH AND MAINTAIN COLLABORATIONS WITH OTHER SCIENTISTS THROUGHOUT THE WORLD, AND TO SHARE RESEARCH RESULTS. DNRG ALSO SUPPORTED PROGRAM ACTIVITIES THROUGHOUT THE YEAR INCLUDING DISTRIBUTION OF EDUCATIONAL MATERIALS AND ORAL PRESENTATIONS TO THE GENERAL PUBLIC. ACTIVITIES CONDUCTED BY DIABETES NATIONAL RESEARCH GROUP HAVE RESULTED IN AN ENORMOUS BENEFIT TO SCIENTISTS THROUGHOUT THE WORLD. OVER THE PAST FEW YEARS, PUBLICATIONS, ORAL PRESENTATIONS, COLLABORATIONS AND THE SHARING OF RESEARCH RESULTS WITH SCIENTISTS AND STUDENTS OCCURRED IN MANY COUNTRIES. AS A RESULT OF THIS SUPPORT WITHIN THE UNITED STATES, SCIENTISTS AND STUDENTS FROM AT LEAST HALF OF THE STATES HAVE BENEFITED BY ATTENDING LECTURES, READING JOURNAL ARTICLES, BEGINNING NEW RESEARCH COLLABORATIONS, AND MAINTAINING ESTABLISHED COLLABORATIVE EFFORTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $6,303
Program Service Revenue $0
Investment Income $3
Other Revenue $0
TOTAL REVENUE $6,306

Expense Breakdown

Grants Paid $27,000
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $32,691
Other Expenses $6,820
TOTAL EXPENSES $33,820

Year-over-Year Comparison

2020 2019 Change
Revenue $6,306 $20,032 -0.7%
Expenses $33,820 $154,644 -0.8%
Net Income $-27,514 $-134,612 -0.8%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
5
Independent Members
3
Employees
N/A
Volunteers
N/A

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
1
$12,691
Total Directors
4
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
RICHARD A HOUGHTEN PRESIDENT/TRUSTEE 1.00
Director
$0 $0 $0
LARRY PELTON TRUSTEE 1.00
Director
$0 $0 $0
GEORGE B THORNTON TRUSTEE 1.00
Director
$0 $0 $0
PATRICIA S WU TRUSTEE 1.00
Director
$0 $0 $0
PAMELA G HOUGHTEN SECRETARY 1.00
Officer
$0 $0 $12,691
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2021 $6,306 $33,820 No data $-27,514
2020 $20,032 $154,644 $25,686 $-134,612
2019 $20,293 $377,917 $168,910 $-357,624
2018 $47,098 $176,977 $522,450 $-129,879
Explore More Nonprofits
Top 100 Nonprofits in Florida Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare DIABETES NATIONAL RESEARCH GROUP with other nonprofits in Florida and across the country.